BOSTON, May 20, 2024 CervoMed Inc. , a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced the appointment of William Elder as Chief.
/PRNewswire/ CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, announced an.
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 11.7 % Diffusion Pharmaceuticals stock opened at $4.40 on Friday. The firm has a 50 day moving average price of $4.64 and a […]
Research analysts at StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ DFFN opened at $4.40 on Friday. The firm has a 50 day moving average of $4.84 […]